MD Anderson receives top Chinese science and technology award

January 16, 2015

The University of Texas MD Anderson Cancer Center was presented the People's Republic of China International Science and Technology Cooperation Award at a ceremony held Jan. 9 at Beijing's Great Hall of the People.

The event, attended by Chinese President Xi Jinping, Premier Li Keqiang, and Vice Premier Liu Yandong, recognized MD Anderson's many international ties to sister institutions in China with which it shares collaborative programs in training, education and patient care. The award is granted through the Chinese State Council to foreign scientists, science and technology engineers and managers, or organizations that have "made important contributions to China's bilateral or multilateral scientific and technological cooperation."

Oliver Bogler, Ph.D., senior vice president for academic affairs accepted the award on behalf of MD Anderson. Ta-Jen Liu, Ph.D., project director of global academic programs, also attended the ceremony.

"Cancer is a significant challenge worldwide," said Bogler. "Every country has a unique spectrum of cancers, influenced by factors such as population and environment, and collaborating to study these cancers is critical to making progress. China in particular offers tremendous opportunities for saving lives through joint cancer research with top scientists and the government's commitment to fighting cancer."

Bogler added that collaborations with Chinese partners have been productive in areas such as cancer screening, liver and lung cancer treatment, and cooperation in clinical trials and basic research studies.

"It is increasingly important to share information and create ties that help all nations in our collective fight against cancer," said Ron DePinho, M.D., president of MD Anderson. "Receiving this coveted award from China is an honor for our institution and one that speaks to our commitment to collaboration, here at home and across the globe."

MD Anderson was nominated for the award by its sister institution, Sun Yat-sen University Cancer Center in Guangzhou. Other MD Anderson sister institutions include the Chinese Academy of Medical Sciences Cancer Institute and Hospital, Beijing; Tianjin Medical University Cancer Institute and Hospital; Fudan University Shanghai Cancer Center; and the Sir YK Pao Centre for Cancer, Chinese University of Hong Kong.

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to